Holloway PM - Search Results

1

Both MC1 and MC3 Receptors Provide Protection From Cerebral Ischemia-Reperfusion-Induced Neutrophil Recruitment.

Holloway PM, Durrenberger PF, Trutschl M, Cvek U, Cooper D, Orr AW, Perretti M, Getting SJ, Gavins FN. Holloway PM, et al. Arterioscler Thromb Vasc Biol. 2015 Sep;35(9):1936-44. doi: 10.1161/ATVBAHA.115.305348. Epub 2015 Jun 25. Arterioscler Thromb Vasc Biol. 2015. PMID: 26112010 Free PMC article.

2

Targeting the melanocortin receptor system for anti-stroke therapy.

Holloway PM, Smith HK, Renshaw D, Flower RJ, Getting SJ, Gavins FN. Holloway PM, et al. Trends Pharmacol Sci. 2011 Feb;32(2):90-8. doi: 10.1016/j.tips.2010.11.010. Epub 2010 Dec 23. Trends Pharmacol Sci. 2011. PMID: 21185610 Review.

3

Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1-FPR2/ALX anti-inflammatory system.

Gavins FN, Hughes EL, Buss NA, Holloway PM, Getting SJ, Buckingham JC. Gavins FN, et al. Among authors: holloway pm. FASEB J. 2012 Dec;26(12):4977-89. doi: 10.1096/fj.12-205971. Epub 2012 Sep 10. FASEB J. 2012. PMID: 22964301

4

Modeling Ischemic Stroke In Vitro: Status Quo and Future Perspectives.

Holloway PM, Gavins FN. Holloway PM, et al. Stroke. 2016 Feb;47(2):561-9. doi: 10.1161/STROKEAHA.115.011932. Epub 2016 Jan 7. Stroke. 2016. PMID: 26742797 Free PMC article. Review. No abstract available.

5

Formyl-Peptide Receptor 2/3/Lipoxin A4 Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease.

Vital SA, Becker F, Holloway PM, Russell J, Perretti M, Granger DN, Gavins FN. Vital SA, et al. Among authors: holloway pm. Circulation. 2016 May 31;133(22):2169-79. doi: 10.1161/CIRCULATIONAHA.115.020633. Epub 2016 May 6. Circulation. 2016. PMID: 27154726 Free PMC article.

6

Sulforaphane induces neurovascular protection against a systemic inflammatory challenge via both Nrf2-dependent and independent pathways.

Holloway PM, Gillespie S, Becker F, Vital SA, Nguyen V, Alexander JS, Evans PC, Gavins FNE. Holloway PM, et al. Vascul Pharmacol. 2016 Oct;85:29-38. doi: 10.1016/j.vph.2016.07.004. Epub 2016 Jul 8. Vascul Pharmacol. 2016. PMID: 27401964 Free PMC article.

7

The isothiocyanate sulforaphane modulates platelet function and protects against cerebral thrombotic dysfunction.

Gillespie S, Holloway PM, Becker F, Rauzi F, Vital SA, Taylor KA, Stokes KY, Emerson M, Gavins FNE. Gillespie S, et al. Among authors: holloway pm. Br J Pharmacol. 2018 Aug;175(16):3333-3346. doi: 10.1111/bph.14368. Epub 2018 Jul 3. Br J Pharmacol. 2018. PMID: 29797311 Free PMC article.

8

(99m)Tc SPECT imaging agent based on cFLFLFK for the detection of FPR1 in inflammation.

Stasiuk GJ, Holloway PM, Rivas C, Trigg W, Luthra SK, Morisson Iveson V, Gavins FN, Long NJ. Stasiuk GJ, et al. Among authors: holloway pm. Dalton Trans. 2015 Mar 21;44(11):4986-93. doi: 10.1039/c4dt02980a. Dalton Trans. 2015. PMID: 25603955

9

Advances in microfluidic in vitro systems for neurological disease modeling.

Holloway PM, Willaime-Morawek S, Siow R, Barber M, Owens RM, Sharma AD, Rowan W, Hill E, Zagnoni M. Holloway PM, et al. J Neurosci Res. 2021 May;99(5):1276-1307. doi: 10.1002/jnr.24794. Epub 2021 Feb 13. J Neurosci Res. 2021. PMID: 33583054 Free article. Review.

10

Novel, Emerging Chip Models of the Blood-Brain Barrier and Future Directions.

Holloway PM. Holloway PM. Methods Mol Biol. 2022;2492:193-224. doi: 10.1007/978-1-0716-2289-6_11. Methods Mol Biol. 2022. PMID: 35733046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters